Skip to the content
Aresma PartnersAresma Partners
Corporate Finance and M&A Advisory Services
  • Approach
  • M&A and Financial Advisory
  • How
  • Contact us
  • Approach
  • M&A and Financial Advisory
  • How
  • Contact us

Author: AresmaPartner

RSS CSRwire Press Releases, Events and Reports

  • Creating a More Accessible Future for Travelers February 7, 2023
    Travel is a force for good and a belief that is central to everything we do at Expedia Group. It guides our commitment to making a positive impact on the world.

RSS TechCrunch

  • Instagram expands access to Reels-focused tipping feature, Gifts February 8, 2023
    Instagram announced today it’s expanding access to a new monetization feature called Gifts to more creators across the U.S. The feature, which first began testing last year, allows fans to provide a favorite creator with direct monetary support in the form of themed virtual gifts. The gifts are purchased in the Instagram app using the […]
  • The individual mistake that tech startups are collectively making February 8, 2023
    Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. This is our Wednesday show, where we niche down to a single person, think about their work and unpack the rest. This week, Natasha interviewed Cleo’s chief business officer and former CEO, SJ […]

RSS VentureBeat

  • Qualcomm unveils 5G modem for a new generation of edge devices February 8, 2023
    Qualcomm Technologies unveiled its Snapdragon X35 5G Modem-RF System, the world’s first 5G NR-Light modem-RF system.

RSS Biotech Finances

  • Hybrigenics, Icosagen, Carbios, LAmAb Biologics, TVM Capital Life Science, Deeplink Medical, Imadis February 8, 2023
    Hybrigenics (ALHYG) a validé l’accord entre DMS Group et la famille ANSEL portant sur la cession par DMS Group de 17,00% de ses actions Hybrigenics au profit du groupe familial ANSEL. Parallèlement, les parties ont conclu un pacte d’actionnaires organisant la gouvernance de la société Hybrigenics autour d’un Conseil d’administration de six membres ayant pour […]
  • Evonetix, Tilt Biotherapeutics, GenSight Biologics February 7, 2023
    En Grande-Bretagne, Evonetix boucle une série B de 24 M$ qui atteint au final 54 M$. Foresite Capital est en position de lead sur le tour, suivi de Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures et Providence. L’investissement permettra à Evonetix d’avancer jusqu’au stade commercial.  Le processus de synthèse de l’entreprise utilise une nouvelle […]
Aresma Partners, 10/35 Howard St, Brisbane City QLD 4000, Australia Australia Contact - 594 a chemin du quartier d'Espagne, 30900 Nimes, Languedoc-Roussillon, Occitanie, France Contact France
To the top ↑ Up ↑
  • France
  • United Kingdom
  • Australia